still wait behavior turn
guidanc color note wednesday ebitda guidanc fair-to-slightli
disappoint view particularli expect uptick behavior volum
instead behavior segment larg expect continu path recent
perform guidanc embed revenu growth volum price
ebitda growth acut side management continu expect revenu ebitda growth
mid-to-high singl rang said finish thur
volatil day trade underscor grow fear coronaviru pandem
acut labor issu persist quarter labor expens remain elev due near-term
staf commit indic particularli challeng environ budget nurs
physician recal volum run except high y/i
attribut henderson facil oper full capac addit management
note underli wage inflat run tick higher today
rang vs year ago final la vega management note hca new contract unh
sierra network result lower volum larg off-set better price
renegoti contract sierra also start
behavior visibl remain investor still wait behavior volum turn
corner new presid matt peterson bring fresh perspect compani
lean manag care background drive opportun partner payor way
that mutual benefici parti howev management quick note longer-
term opportun wouldnt necessarili impact near-term result
reiter ew follow result initi guidanc trim net
ebitda mn mn net ebitda bn bn
price target decreas base target multipl new
net ebitda balanc sheet estim pg color key oper metric
quarterli annual ep usd
lower usd
idc link barclay live interact chart
moder quarter character norm step bp
return equiti ttm
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
perform well howev behavior segment
struggl hit same-stor growth target due
tight labor market clinician drag ebitda
behavior volum same-stor revenu rebound
hit growth target lead stronger
ebitda growth multipl expans
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
behavior growth deceler difficulti
recruit retain clinician persist lead
weaker expect ebitda
behavior offset acut ebitda guid captur consensu high end
y/i ebitda bpsnmdepreci incom net average vs barclay
 incom statement total wage oper rental high-tech ebitda incom ebit expens tax rate ep share barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
procedur pleas
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
